NEW YORK (GenomeWeb News) — Invitrogen said Wednesday that its second-quarter revenue climbed 13 percent as R&D spending rose 11 percent and net income was up 108 percent.
 
Total receipts for the three months ended June 30, 2007 rose to $321.7 million from $285.4 million year over year.
 
Invitrogen’s Biodiscovery sales rose 10 percent to $223 million for the second quarter, while its Cell Culture Systems division saw revenue rise 20 percent to $99 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.